Overview / Abstract: |
STATEMENT OF NEED Myeloproliferative neoplasms are a heterogeneous group of hematopoietic disorders that includes myelofibrosis, polycythemia vera (PV), and essential thrombocythemia (ET). These malignancies affect approximately 13,000, 134,000, and 148,000 individuals in the United States, respectively. As symptoms do not typically manifest in early stages, patients with MPNs often present with advanced disease. The presence of comorbidities precludes most from potentially curative allogeneic stem cell transplant. Due to the dearth of effective treatment options, therapeutic goals are focused on slowing progression and maintaining quality of life. Median overall survival varies across MPN subtypes, ranging from 15.4 years for patients with low-risk disease to 1.3 years for those with high-risk disease. Furthermore, MPNs are also associated with a risk for transformation to acute myeloid leukemia, where the 5-year overall survival rate is only 25%. TARGET AUDIENCE Oncology nurses, nurse practitioners, clinical nurse specialists, and other health care professionals involved in the management of patients with myelofibrosis. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: 1.) Identify the clinical signs and symptoms of myelofibrosis |
Expiration |
Mar 10, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 NCPD |
Accreditation |
ANCC |
Presenters / Authors / Faculty |
Alice Lynn, ANP (Chairperson) Dawn C. Urbanovsky, RN, BSN, OCN® |
Sponsors / Supporters / Grant Providers |
This activity is supported by an independent educational grant from Incyte. |
Keywords / Search Terms |
i3 Health i3 Health i3 Health, myelofibrosis, MF, online CNE, free CNE, free CE CME, free CE CME, free CE CME, NCPD, free NCPD, online NCPD, online NCPD CME Free CE CME |